1-20 of 75
Authors: Robert Prins
Sort by
Journal Article
Diffusion and contrast-enhancement MRI phenotypes associated with immune checkpoint inhibitor exposure and with immune cell infiltration in brain metastases Open Access
Francesco Sanvito and others
Neuro-Oncology, noaf084, https://doi.org/10.1093/neuonc/noaf084
Published: 22 March 2025
Journal Article
CTIM-28. NEOADJUVANT ANTI-PD1 IMMUNOTHERAPY FOR SURGICALLY ACCESSIBLE RECURRENT GLIOBLASTOMA: CLINICAL AND MOLECULAR OUTCOMES OF A STAGE 2 SINGLE-ARM EXPANSION COHORT Free
J Ricardo McFaline-Figueroa and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii92, https://doi.org/10.1093/neuonc/noae165.0361
Published: 11 November 2024
Journal Article
SURG-58. COLD ATMOSPHERIC PLASMA (CAP) CAUSES SELECTIVE TUMOR CELL DEATH VIA APOPTOSIS AND FERROPTOSIS IN MALIGNANT GLIOMA CELLS Free
Sophie Peeters and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii287, https://doi.org/10.1093/neuonc/noae165.1137
Published: 11 November 2024
Journal Article
TMIC-63. DUAL IMMUNE CHECKPOINT BLOCKADE IN A NOVEL EGFR-DRIVEN MURINE GLIOMA MODEL INCREASES PERIPHERAL T CELL PROLIFERATION BUT FAILS TO PROLONG SURVIVAL Free
Marissa Li and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii312–viii313, https://doi.org/10.1093/neuonc/noae165.1241
Published: 11 November 2024
Journal Article
TMIC-83. ABERRANT EGFR ACTIVATION SUPPORTS ENHANCED TUMOR-MYELOID CROSSTALK AND IMPAIRS EFFECTOR T CELL INFILTRATION AND FUNCTION IN GLIOBLASTOMA Free
Marissa Pioso and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii317, https://doi.org/10.1093/neuonc/noae165.1260
Published: 11 November 2024
Journal Article
IMMU-23. NEOADJUVANT ANTI-PD-1 AND ANTI-CTLA-4 COMBINATION THERAPY INDUCED INTRATUMORAL IMMUNOLOGIC ALTERATIONS IN RECURRENT GBM PATIENTS Free
Lauren Markus and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii157, https://doi.org/10.1093/neuonc/noae165.0616
Published: 11 November 2024
Journal Article
TMIC-81. AN IMMUNOSUPPRESSIVE MACROPHAGE NICHE MAY DRIVE T CELL DYSFUNCTION AND IMMUNOTHERAPY RESISTANCE IN MELANOMA BRAIN METASTASES Free
Lu Sun and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii316–viii317, https://doi.org/10.1093/neuonc/noae165.1258
Published: 11 November 2024
Journal Article
IMMU-49. TARGETING ALTERNATIVE SPLICING VARIANTS TO STIMULATE ANTI-TUMOR IMMUNITY IN A NOVEL SYNGENEIC MOUSE MODEL OF DIFFUSE HEMISPHERIC GLIOMA, H3 G34-MUTANT Free
Anthony Wang and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii163–viii164, https://doi.org/10.1093/neuonc/noae165.0642
Published: 11 November 2024
Journal Article
CTIM-34. EFFECTS OF NEOADJUVANT IMMUNE CHECKPOINT INHIBITION ON PEDIATRIC AND ADULT HIGH-GRADE GLIOMAS Free
Hadar Keren-Gill and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii93, https://doi.org/10.1093/neuonc/noae165.0367
Published: 11 November 2024
Journal Article
IMMU-05. CD8 IMMUNOPET IMAGING IS ABLE TO MONITOR THE IMMUNE RESPONSE SENSITIVELY AND SPECIFICALLY IN GBM PATIENTS FOLLOWING NEOADJUVANT CHECKPOINT BLOCKADE IMMUNOTHERAPY Free
Robert Prins and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v142, https://doi.org/10.1093/neuonc/noad179.0537
Published: 10 November 2023
Journal Article
IMMU-03. UTILIZING IN SILICO SINGLE-CELL TRANSCRIPTOMIC AND TCR PROFILING FOR THE IDENTIFICATION AND ISOLATION OF TUMOR-REACTIVE TCR CLONOTYPES IN RECURRENT GLIOBLASTOMA PATIENTS Free
Alexander Lee and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v141, https://doi.org/10.1093/neuonc/noad179.0535
Published: 10 November 2023
Journal Article
RBIO-11. BASAL BCL-2-INTERACTING MEDIATOR OF CELL DEATH (BIM) RESPONSIVENESS CORRELATES WITH RADIOSENSITIVITY IN MENINGIOMA Free
Maya Harary and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v258, https://doi.org/10.1093/neuonc/noad179.0991
Published: 10 November 2023
Journal Article
TMIC-74. SPATIAL LANDSCAPE OF MELANOMA BRAIN METASTASES WITH AND WITHOUT PRE-SURGICAL IMMUNE CHECKPOINT BLOCKADE Free
Lu Sun and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v295, https://doi.org/10.1093/neuonc/noad179.1139
Published: 10 November 2023
Journal Article
IMMU-30. NOVEL HYPOMETHYLATING AGENT GSK-3484862 SENSITIZES GLIOBLASTOMA TO NY-ESO-1 SPECIFIC IMMUNOTHERAPY Free
Kevin Li and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v148, https://doi.org/10.1093/neuonc/noad179.0562
Published: 10 November 2023
Journal Article
IMMU-13. DEVELOPMENT OF ADAPTIVE IMMUNE RESISTANCE IN A MURINE GLIOMA MODEL TREATED WITH DENDRITIC CELL VACCINATION AND PD-1 CHECKPOINT BLOCKADE Free
Gilbert Herrera and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v144, https://doi.org/10.1093/neuonc/noad179.0545
Published: 10 November 2023
Journal Article
IMMU-40. DECITABINE PRIMES GLIOBLASTOMA TO NY-ESO-1 SPECIFIC T-CELL CYTOLYSIS VIA DNA DEMETHYLATION OF NY-ESO-1, CANCER-TESTIS ANTIGENS, AND PRO-INFLAMMATORY SIGNATURES Free
Thomas Lai and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v151, https://doi.org/10.1093/neuonc/noad179.0572
Published: 10 November 2023
Journal Article
IMMU-38. INTRATUMORAL CORRELATION OF MULTIPLEX IMMUNOFLUORESCENCE AND89ZR-CREFMIRLIMAB BERDOXAM IMMUNOPET IN RECURRENT GBM PATIENTS TREATED WITH NEOADJUVANT ANTI-PD-1 +/- ANTI-CTLA-4 THERAPY Free
Lauren Markus and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v150–v151, https://doi.org/10.1093/neuonc/noad179.0570
Published: 10 November 2023
Journal Article
IMMU-04. TARGETING ALTERNATIVE SPLICING VARIANTS TO STIMULATE ANTI-TUMOR IMMUNITY IN A NOVEL SYNGENEIC MOUSE MODEL OF DIFFUSE HEMISPHERIC GLIOMA, H3 G34-MUTANT Open Access
Geoffrey Owens and others
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Pages i49–i50, https://doi.org/10.1093/neuonc/noad073.191
Published: 12 June 2023
Journal Article
IMMU-13. PROMOTER DEMETHYLATION OF NY-ESO-1 PRIMES GLIOBLASTOMA FOR IMMUNOTHERAPEUTIC TARGETING Free
Thomas Lai and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii133–vii134, https://doi.org/10.1093/neuonc/noac209.511
Published: 14 November 2022
Journal Article
NIMG-48. MULTI-ECHO SPIN-AND-GRADIENT ECHO (SAGE) PERFUSION MRI TO EVALUATE BRAIN TUMOR MICROSTRUCTURE AND MICROVASCULATURE Free
Francesco Sanvito and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii174, https://doi.org/10.1093/neuonc/noac209.666
Published: 14 November 2022
Advertisement
Advertisement